IDH1/2 mutations are heterozygous and occur mostly at residues R132 in IDH1, and R140 or R172 in IDH2. IDH1 and IDH2 mutations are mutually exclusive with TET2 mutations in AML, suggesting that they play a similar mechanistic role. This evidence concerns the gene TET2 and acute myeloid leukemia.